Innovación contra el cancer

Dave Craig is a two-time cancer survivor, oncology researcher and patient experience champion. After 10 years of struggling to see his own cancer journey in the patient experience research he led for the pharmaceutical industry, he left to use his survivor heart and researcher brain to help other patients. In 2016, he co-founded GRYT (“grit”) Health, a digital oncology solutions company that empowers people to be in charge of their own health through education, engagement, and support, and has served as the chief executive officer since its inception. At GRYT Health, he and his team of fellow survivors and caregivers, use their expertise and personal experiences to support the industry and create new and innovative ways to help others navigate their journey.

Dave has a bachelor’s of science in Technical Communication and MBA in Technology Management, from Rochester Institute of Technology.  He has completed Executive Education at Harvard Business School in Building New Ventures and at MIT in Corporate Strategy.

Kamala Maddali is a clinically trained veterinarian who earned her doctorate in veterinary medicine from Sri Venkateswara Veterinary University in India and a PhD in pharmacology from the University of Missouri-Columbia. Dr. Maddali is a native of Andhra Pradesh, India. With Fortune 100 and 500 companies like Merck & Co, Quintiles, IQVIA, and Quest Diagnostics, Maddali has extensive experience in precision medicine. Over the last two decades, she has worked on implementing corporate strategy initiatives to advance precision medicine. As a visionary leader who fosters collaboration between the medical, patient, and healthcare innovation sectors, Dr. Maddali has strong medical, scientific, and rare disease roots.

As a Precision Medicine expert, she specializes in biomarkers, companion diagnostics, devices, therapeutics, recruitment, engagement, patient experience, and empowerment of patients. She has served on the boards, advisory boards, and advisory committees of a variety of biotech, diagnostics, healthcare technology companies developing solutions in the fields of artificial intelligence, digital health, and precision medicine. Her board roles in patient advocacy and support groups like Colontown and Adira Foundation could be an asset in converging precision medicine, clinical trials, and clinical research.

Dr. Maddali is the author of "Becoming a Kamala" a memoir focused on her unique journey which unveils her various avatars in her pursuit towards becoming a better human, woman and a rare disease patient. In 2021, Dr. Kamala Maddali was awarded Pharma Voice 2021 Top 100 Most Inspiring Leaders in the Life Sciences and Healthcare Industry. The award is a prestigious and honorable recognition to be a part of a select group of leaders, mentors, and visionaries in the Life Sciences who inspire change across their organizations, including Fortune 100 and 500 companies.

Dr. Maddali has been nominated to serve as a founding member of Chief in 2022 by a few Fortune 100 executives, a private network designed for the most powerful and impactful women in executive leadership who wish to build their leadership skills, increase their influence, and inspire others.

Due to her personal experience of suffering from a rare disease such as MS and Parkinson's, Dr. Maddali views innovation as a powerful tool for restoring hope for everyone; opening up her innovative mind to cutting edge integrative solutions such as regenerative medicine, phytotherapy, etc.

Ryan has been with CURE since February 2020 and has previously covered medical news across several specialties prior to joining MJH Life Sciences. He is a graduate of Temple University, where he studied journalism and minored in political science and history. He considers himself a craft beer snob and would like to open a brewery in the future. During his spare time, he can be found rooting for all major Philadelphia sports teams.